Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

NCT06039384 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT06039384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06039384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Terminated
Start date
December 28, 2023
Completion date
July 11, 2025
Enrollment
6 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors